Published by Josh White on 27th April 2023
(Sharecast News) - Global pharmaceuticals firm Merck said in its first-quarter earnings on Thursday that, despite a 9% decrease in total worldwide sales year-on-year to $14.49bn, it saw a "strong underlying performance" across key growth drivers, particularly in oncology and vaccines.
URL: http://www.digitallook.com/dl/news/story/33465576/...